Your leader returns to his adoring subjects. Subcu MNTX is approved and has clocked some initial sales, which are at a level I would describe as encouraging. While Progenics won't become profitable based on this, it gives them some cushion as they… More
I cannot understand the valuation on this stock. The only product submitted for FDA approval is subcutaneous methylnaltrexone. An injection for constipation? A shot for a sh-t? I don't predict roaring sales. The real money is in the oral formulation… More